Santa Cruz Biotechnology delivers a wide array of GIOT-1 monoclonal antibodies for various research applications. GIOT-1 monoclonal antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GIOT-1, or GTPase of immunity-associated protein 1, plays a crucial role in immune response regulation and cellular signaling pathways. GIOT-1's involvement in the modulation of immune cell functions highlights its significance in understanding various diseases, including autoimmune disorders and cancer. Research focused on GIOT-1 continues to reveal new insights into cellular mechanisms and potential therapeutic targets. Understanding GIOT-1's role in immune regulation has become increasingly important for developing new treatment approaches. Investigating GIOT-1 expression patterns and interactions provides valuable information about disease progression and potential interventions. GIOT-1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of immune system regulation and contribute to breakthrough discoveries in biomedical science.